Parkinson’s Doubles Hip Fracture Risk, Yet Osteoporosis Drugs Are No More Likely After Breaks
A nationwide Finnish cohort study found that people with Parkinson's disease receive anti-osteoporosis medications at rates similar to or higher than matched controls, yet only abo...